| 引用本文: |
周佳丽, 卢晋, 李文艳, 彭瀛娴, 张谦, 苏维, 刘晓丹.黄芪多糖通过Sonic hedgehog通路调控脑微血管周细胞定向分化抗脑缺血再灌注髓鞘损伤[J].湖南中医药大学学报,2026,46(10):2008-2018[点击复制] |
|
| |
|
|
| 本文已被:浏览 288次 下载 323次 |
| 黄芪多糖通过Sonic hedgehog通路调控脑微血管周细胞定向分化抗脑缺血再灌注髓鞘损伤 |
| 周佳丽,卢晋,李文艳,彭瀛娴,张谦,苏维,刘晓丹 |
| (湖南中医药大学, 湖南 长沙 410208;中西医结合心脑疾病防治湖南省重点实验室, 湖南 长沙 410208) |
| 摘要: |
| 目的 探讨黄芪多糖(APS)通过音猬因子(Shh)信号通路调控脑微血管周细胞(BMPCs)增殖活化,并促进少突胶质前体细胞(OPCs)介导的髓鞘修复,从而减轻脑缺血再灌注后髓鞘损伤的作用机制。方法 采用大脑中动脉栓塞/再灌注(MCAO/R)法建立脑缺血再灌注大鼠模型,将100只SD大鼠随机分为假手术组、模型组、APS低、中、高剂量组(30、60、120 mg·kg-1)及丁苯酞组(80 mg·kg-1)。连续给药2 d后,采用Longa神经功能缺损评分评估神经损伤程度;2,3,5-三苯基氯化四氮唑(TTC)染色法评估模型建立情况;Morris水迷宫实验检测学习记忆能力;转棒实验检测运动协调能力;HE染色和尼氏染色观察脑组织病理改变;劳克坚牢蓝(LFB)染色观察脑组织髓鞘损伤情况;免疫荧光法观察BMPCs标志物血小板衍生生长因子受体-β(PDGFR-β)与少突胶质细胞(OLs)标志物髓鞘碱性蛋白(MBP)的共定位表达,以及OPCs标志物神经元胶质抗原2(NG2)与OLs标志物MBP的共定位表达;Western blot检测脑组织中NG2、PDGFR-β、胶质瘤相关癌基因同源蛋白1(Gli1)、Shh、MBP的蛋白表达水平。结果 与假手术组比较,模型组大鼠逃逸潜伏期显著延长(P<0.05),穿越平台次数显著减少(P<0.01),在棒持续时间显著降低(P<0.01),脑组织病理损伤和髓鞘损伤显著加重(P<0.01),BMPCs增殖率降低(P<0.05),PDGFR-β/MBP及NG2/MBP共定位水平降低(P<0.05,P<0.01),NG2、PDGFR-β、Gli1、Shh及MBP蛋白表达水平降低(P<0.05,P<0.01)。与模型组比较,APS低、中、高剂量组及丁苯酞组逃逸潜伏期缩短(P<0.05,P<0.01),穿越平台次数显著增加(P<0.05,P<0.01),在棒持续时间显著升高(P<0.01),脑组织病理损伤和髓鞘脱失减轻(P<0.05,P<0.01),BMPCs增殖率升高(P<0.05,P<0.01),PDGFR-β/MBP及NG2/MBP共定位水平升高(P<0.05,P<0.01),NG2、PDGFR-β、Gli1、Shh及MBP蛋白表达水平升高(P<0.05,P<0.01)。结论 APS可减轻脑缺血再灌注髓鞘损伤,改善神经、学习记忆、运动功能缺损,其作用机制可能与激活Shh信号通路、调控BMPCs增殖活化并协同促进OPCs介导的髓鞘再生有关。 |
| 关键词: 脑缺血|髓鞘损伤|黄芪多糖|周细胞|Sonic hedgehog通路 |
| DOI:10.3969/j.issn.1674-070X.2026.10.005 |
| 投稿时间:2026-08-05 |
| 基金项目:湖南省自然科学基金项目(2025JJ90037);湖南省教育厅重点项目(24A0270);湖南中医药大学研究生科研创新项目(2025CX070);湖南省大学生创新训练计划项目(S202410541026);湖南中医药大学本科生科研创新基金项目(2024BKS043)。 |
|
| Astragalus polysaccharides protect against cerebral ischemia-reperfusion-induced myelin damage by regulating the directed differentiation of brain microvascular pericytes via the Sonic hedgehog pathway |
| ZHOU Jiali, LU Jin, LI Wenyan, PENG Yingxian, ZHANG Qian, SU Wei, LIU Xiaodan |
| (Hunan University of Chinese Medicine, Changsha, Hunan 410208, China;Hunan Key Laboratory of Integrated Chinese and Western Medicine for Prevention and Treatment of Heart and Brain Diseases, Changsha, Hunan 410208, China) |
| Abstract: |
| Objective To investigate the mechanism of action by which Astragalus polysaccharides (APS) regulate the proliferation and activation of brain microvascular pericytes (BMPCs) through the Sonic hedgehog (Shh) signaling pathway and promote oligodendrocyte precursor cells (OPCs)-mediated myelin repair, thereby alleviating myelin damage after cerebral ischemia-reperfusion. Methods A rat model of cerebral ischemia-reperfusion was established via middle cerebral artery occlusion/reperfusion (MCAO/R). A total of 100 SD rats were randomly divided into sham-operated group, model group, low-, medium-, and high-dose APS groups (30, 60, and 120 mg·kg-1, respectively), and butylphthalide group (80 mg·kg-1). After two days of continuous administration, the degree of neurological impairment was assessed using the Longa neurological deficit score; model establishment was evaluated by 2,3,5-triphenyltetrazolium chloride (TTC) staining; learning and memory ability was tested by the Morris water maze; motor coordination was assessed by the rotarod test; pathological changes in brain tissue were observed by HE staining and Nissl staining; myelin damage in brain tissue was observed by Luxol fast blue (LFB) staining; immunofluorescence was used to observe the co-localized expression of the BMPC marker platelet-derived growth factor receptor-β (PDGFR-β) with the oligodendrocyte (OL) marker myelin basic protein (MBP), and the co-localized expression of the OPC marker neuron-glial antigen 2 (NG2) with the OL marker MBP; Western blot was used to determine the protein expression levels of NG2, PDGFR-β, glioma-associated oncogene homolog 1 (Gli1), Shh, and MBP in brain tissue. Results Compared with the sham-operated group, rats in the model group showed prolonged escape latency (P<0.05), reduced number of platform crossings (P<0.01), decreased time on the rod (P<0.01), aggravated brain pathological injury and myelin demyelination (P<0.01), a reduced BMPCs proliferation rate (P<0.05), decreased PDGFR-β/MBP and NG2/MBP co-localization levels (P<0.05, P<0.01), and decreased protein expression levels of NG2, PDGFR-β, Gli1, Shh, and MBP (P<0.05, P<0.01). Compared with the model group, the low-, medium-, and high-dose APS groups and the butylphthalide group showed shortened escape latency (P<0.05, P<0.01), increased number of platform crossings (P<0.05, P<0.01), increased time on the rod (P<0.01), alleviated brain pathological injury and myelin demyelination (P<0.05, P<0.01), an increased BMPC proliferation rate (P<0.05, P<0.01), increased PDGFR-β/MBP and NG2/MBP co-localization levels (P<0.05, P<0.01), and increased protein expression levels of NG2, PDGFR-β, Gli1, Shh, and MBP (P<0.05, P<0.01). Conclusion APS can ameliorate myelin damage and neurological, learning and memory, and motor function deficits after cerebral ischemia-reperfusion. The mechanism of action may be related to activating the Shh signaling pathway, regulating the proliferation and activation of BMPCs, and synergistically promoting OPC-mediated myelin regeneration. |
| Key words: cerebral ischemia|myelin damage|Astragalus polysaccharides|pericytes|Sonic hedgehog pathway |
|
 二维码(扫一下试试看!) |
|
|
|
|